Fv

Felix von Coerper

Managing partner ALS Investment Fund

Amsterdam, North Holland

Invests in

Stages:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Managing Partner

    2015

    www.alsinvestmentfund.com

  • Founder

    2014

    MySample Device & Geniplex develop and market (self) sampling devices and tests (IVD) for applications in Women's Health and STD's.

  • Owner

    2002

    Advice & Project Management Life Science projects

2015 - 2016

  • Head Business Development (interim)

    2015 - 2016

2014 - 2015

  • Senior Advisor

    2014 - 2015

    Advisor to the founders of SIRE Life Sciences.

2013 - 2015

  • Senior Advisor

    2013 - 2015

    (Business) development of a new cardiac micro catheter to measure FFR (fractional flow reserve).

2010 - 2014

  • Founder & CEO

    2010 - 2014

    VasCo develops a minimal invasive bypass for cardiovascular surgery, spin-off from Elana BV. Now called Corvasco BV.

  • Founder

    2012 - 2012

    www.bt-i.org BTI's mission is to improve the quality of life for people with neurovascular diseases by maintaining a leading edge in cerebral vascular research and through the development and making available of unique therapies for patients in selected excellence centers.

2004 - 2012

  • Founder & CEO

    2004 - 2012

    Elana developed and introduced a new operating technique that enabled a bypass for major arteries in the brain, using an implant and a laser catheter for the connection and opening of the blood vessels. 2003 - Founder & director (marketing / sales / new business development) 2007 - President Elana USA 2010 - CEO Elana BV

  • Founder & director

    1997 - 2002

    Area010 was the first university incubator in The Netherlands. Located in the World Trade Center, Area010 was focussing on supporting mainly ICT start-ups deriving from the Erasmus University, Rotterdam School of Management, Hogeschool Rotterdam and Hogeschool Inholland.